[1] |
薛秀娟, 代贝贝, 毕建伟, 等. 重症血液净化护理质量评价指标体系的构建[J]. 中国实用护理杂志, 2020, 36(7):538-543.
|
|
Xue XJ, Dai BB, Bi JW, et al. Construction of quality evaluation index system for blood purification nursing care in ICU[J]. Chin J Pract Nurs, 2020, 36(7):538-543.
|
[2] |
宋艳, 张沁莲, 刘义婷, 等. 成年血液透析患者不同封管液应用效果的网状Meta分析[J]. 护理学杂志, 2019, 34(13):52-56.
|
|
Song Y, Zhang QL, Liu YT, et al. Effect of various locking solutions for hemodialysis catheters in adults patients:a network meta analysis[J]. J Nurs Sci, 2019, 34(13):52-56.
|
[3] |
Al-Ali F, Hamdy AF, Hamad A, et al. Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients:a prospective,randomized,controlled study[J]. Nephrol Dial Transplant, 2018, 33(4):619-626.
DOI
URL
|
[4] |
韩新, 曹艳佩, 杨晓莉, 等. 经中心静脉导管血液透析患者不同种类封管液的应用进展[J]. 护士进修杂志, 2016, 31(6):507-510.
|
|
Han X, Cao YP, Yang XL, et al. Application progress of different types of sealing fluids in patients undergoing central venous catheter hemodialysis[J]. J Nurses Train, 2016, 31(6):507-510.
|
[5] |
金其庄, 王玉柱, 叶朝阳, 等. 中国血液透析用血管通路专家共识(第2版)[J]. 中国血液净化, 2019, 18(6):365-381.
|
|
Jin QZ, Wang YZ, Ye ZY, et al. Consensus among experts on blood access used for hemodialyis in China(2nd edition)[J]. Chin J Blood Purif, 2019, 18(6):365-381.
|
[6] |
刘云访, 喻姣花, 黄海燕, 等. ICU中心静脉导管相关性血流感染预防的证据总结[J]. 护士进修杂志, 2020, 35(4):319-325,333.
|
|
Liu YF, Yu JH, Huang HY, et al. Evidence summary for prevention of central venous catheter associated bloodstream infection in intensive care unit[J]. J Nurses Train, 2020, 35(4):319-325,333.
|
[7] |
Hill B, Smith C. Central venous pressure monitoring in critical care settings[J]. Br J Nurs, 2021, 30(4):230-236.
DOI
URL
|
[8] |
Parienti JJ, Thirion M, Mégarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy:a randomized controlled trial[J]. JAMA, 2008, 299(20):2413-2422.
DOI
URL
|
[9] |
Lok CE, Huber TS, Lee T, et al. KDOQI clinical practice guideline for vascular access:2019 update[J]. Am J Kidney Dis, 2020, 75(Suppl 2):S1-S164.
|
[10] |
Clark WR, Ding XQ, Qiu HB, et al. Renal replacement therapy practices for patients with acute kidney injury in China[J]. PLoS One, 2017, 12(7):e0178509.
DOI
URL
|
[11] |
Peng XB, Xie XM, Yin J, et al. Anticoagulation effect and safety observation of regional citrate anticoagulation for double-filtration plasmapheresis in critical patients[J]. Blood Purif, 2020, 49(5):542-549.
DOI
URL
|
[12] |
韩新, 曹艳佩, 杨晓莉, 等. 枸橼酸盐和肝素钠用于成人血液透析导管封管有效性的Meta分析[J]. 护理学杂志, 2015, 30(21):88-92.
|
|
Han X, Cao YP, Yang XL, et al. The effectiveness of citrate lock versus heparin lock for central venous catheter in adult hemodialysis patients:a Meta-analysis of randomized controlled trials[J]. J Nurs Sci, 2015, 30(21):88-92.
|
[13] |
Chang H, Gong YY, Li CX, et al. Clinical efficacy of regional citrate anticoagulation in continuous renal replacement therapy:systematic review and meta-analysis[J]. Ann Palliat Med, 2021, 10(8):8939-8951.
DOI
PMID
|
[14] |
Yon CK, Low CL. Sodium citrate 4% versus heparin as a lock solution in hemodialysis patients with central venous catheters[J]. Am J Health Syst Pharm, 2013, 70(2):131-136.
DOI
URL
|
[15] |
血液净化急诊临床应用专家共识组. 血液净化急诊临床应用专家共识[J]. 中华急诊医学杂志, 2017, 26(1):24-36.
|
|
Expert Consensus Group on Clinical Application of Blood Purification Emergency. Expert consensus on emergency clinical application of blood purification[J]. Chin J Emerg Med, 2017, 26(1):24-36.
|
[16] |
Gorski LA, Hadaway L, Hagle ME, et al. Infusion therapy standards of practice,8th edition[J]. J Infus Nurs, 2021, 44(Suppl 1):S1-S224.
DOI
URL
|
[17] |
Sheng KX, Zhang P, Li JW, et al. Comparative efficacy and safety of lock solutions for the prevention of catheter-related complications including infectious and bleeding events in adult haemodialysis patients:a systematic review and network meta-analysis[J]. Clin Microbiol Infect, 2020, 26(5):545-552.
DOI
URL
|
[18] |
Grudzinski A, Agarwal A, Bhatnagar N, et al. Benefits and harms of citrate locking solutions for hemodialysis catheters:a systematic review and meta-analysis[J]. Can J Kidney Health Dis, 2015, 2:13.
|
[19] |
Schilcher G, Scharnagl H, Horina JH, et al. Trisodium citrate induced protein precipitation in haemodialysis catheters might cause pulmonary embolism[J]. Nephrol Dial Transplant, 2012, 27(7):2953-2957.
DOI
URL
|
[20] |
Correa Barcellos F, Pereira Nunes B, Jorge Valle L, et al. Comparative effectiveness of 30% trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters:a randomized controlled trial (CITRIM trial)[J]. Infection, 2017, 45(2):139-145.
DOI
PMID
|
[21] |
Luiz MV, Scavone C, Tzanno C. The CLOCK trial,a double-blinded randomized controlled trial:trisodium citrate 30% and minocycline 3 mg/ml plus EDTA 30 mg/ml are effective and safe for catheter patency maintenance among CKD 5D patients on hemodialysis[J]. Hemodial Int, 2017, 21(2):294-304.
DOI
URL
|
[22] |
Huang HM, Jiang X, Meng LB, et al. Reducing catheter-associated complications using 4% sodium citrate versus sodium heparin as a catheter lock solution[J]. J Int Med Res, 2019, 47(9):4204-4214.
DOI
URL
|
[23] |
Polaschegg HD. Catheter locking-solution spillage:theory and experimental verification[J]. Blood Purif, 2008, 26(3):255-260.
DOI
URL
|
[24] |
Zhao YL, Li Z, Zhang L, et al. Citrate versus heparin lock for hemodialysis catheters:a systematic review and meta-analysis of randomized controlled trials[J]. Am J Kidney Dis, 2014, 63(3):479-490.
DOI
URL
|
[25] |
马元吉, 许艳, 白浪, 等. 肝素钠与枸橼酸钠封管液在人工肝治疗肝衰竭患者的应用比较[J]. 实用肝脏病杂志, 2020, 23(1):66-69.
|
|
Ma YJ, Xu Y, Bai L, et al. Comparison of citrate to heparin as a catheter locking solution in patients with liver failure undergoing artificial liver support therapy[J]. J Pract Hepatol, 2020, 23(1):66-69.
|
[26] |
Wei YJ, Yang JW, Boddu SH, et al. Compatibility, stability,and efficacy of vancomycin combined with gentamicin or ethanol in sodium citrate as a catheter lock solution[J]. Hosp Pharm, 2017, 52(10):685-690.
DOI
URL
|
[27] |
Reidenberg BE, Wanner C, Polsky B, et al. Postmarketing ex-perience with Neutrolin(taurolidine,heparin,calcium citrate) catheter lock solution in hemodialysis patients[J]. Eur J Clin Microbiol Infect Dis, 2018, 37(4):661-663.
DOI
URL
|
[28] |
Aniort J, Piraud A, Adda M, et al. Evaluation of the efficacy of an interdialytic “ethanol 40% v/v-enoxaparin 1 000 U/ml” lock solution to prevent tunnelled catheter infections in chronic hemodialysis patients:a multi-centre,randomized,single blind,parallel group study[J]. BMC Nephrol, 2019, 20(1):149.
DOI
URL
|
[29] |
孙红, 陈利芬, 郭彩霞, 等. 临床静脉导管维护操作专家共识[J]. 中华护理杂志, 2019, 54(9):1334-1342.
|
|
Sun H, Chen LF, Guo CX, et al. Expert consensus on venous catheter maintenance[J]. Chin J Nurs, 2019, 54(9):1334-1342.
|
[30] |
Bruyère R, Soudry-Faure A, Capellier G, et al. Comparison of heparin to citrate as a catheter locking solution for non-tunneled central venous hemodialysis catheters in patients requiring renal replacement therapy for acute renal failure (VERROU-REA study):study protocol for a randomized controlled trial[J]. Trials, 2014, 15:449.
DOI
PMID
|
[31] |
Lenz JR, Degnan DD, Hertig JB, et al. A review of best practices for intravenous push medication administration[J]. J Infus Nurs, 2017, 40(6):354-358.
DOI
URL
|
[32] |
韩柳, 杨宏艳, 刘飞, 等. 无针输液接头临床应用的最佳证据总结[J]. 中华护理杂志, 2020, 55(8):1239-1246.
|
|
Han L, Yang HY, Liu F, et al. Evidence summary for clinical application of needle-free infusion connector[J]. Chin J Nurs, 2020, 55(8):1239-1246.
|
[33] |
姜艳华, 邢唯杰, 周兴梅, 等. 连续性肾脏替代治疗患者中心静脉导管维护的最佳证据总结[J]. 护士进修杂志, 2021, 36(6):533-539.
|
|
Jiang YH, Xing WJ, Zhou XM, et al. Best evidence summary for central venous catheter maintenance in patients with continuous renal replacement therapy[J]. J Nurses Train, 2021, 36(6):533-539.
|